BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19

• Press Releases

  Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity

  September 18, 2025

   · 

  6 min read
• Press Releases

  Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 17, 2025

  September 18, 2025

   · 

  2 min read
• Press Releases

  Bristol Myers Squibb Announces Dividend - September 17, 2025

  September 18, 2025

   · 

  1 min read
• Press Releases

  Lilly’s oral GLP-1, orforglipron, superior to oral semaglutide in head-to-head trial

  September 18, 2025

   · 

  11 min read
• Press Releases

  NovalGen to Begin World’s First Clinical Trial for a Self-Regulating Immunotherapy

  September 18, 2025

   · 

  5 min read
• Press Releases

  ADARx Pharmaceuticals Appoints Industry Veteran, Laura Shawver, Ph.D., as Board Chair

  September 18, 2025

   · 

  2 min read
• Press Releases

  Ollin Biosciences Launches with Mission to Accelerate Best-in-class Therapies in Ophthalmology

  September 18, 2025

   · 

  7 min read
• Press Releases

  MapLight Therapeutics Announces Initiation of Phase 2 Trial of Novel M1/M4 Muscarinic Agonist ML-007C-MA for the Treatment of Alzheimer’s Disease Psychosis

  September 18, 2025

   · 

  3 min read
• Press Releases

  Palisade Bio Reports Positive PALI-2108 Phase 1b Clinical Data

  September 18, 2025

   · 

  6 min read
• Press Releases

  Intelligent Bio Solutions Provides Update on FDA 510(k) Clearance Process for Intelligent Fingerprinting Drug Screening System

  September 18, 2025

   · 

  4 min read